• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物流体中卡托普利及其二硫化物的测定。

Determination of captopril and its disulphide in biological fluids.

作者信息

Matsuki Y, Ito T, Fukuhara K, Nakamura T, Kimura M, Ono H

出版信息

J Chromatogr. 1982 Apr 30;239:585-94. doi: 10.1016/s0021-9673(00)82016-6.

DOI:10.1016/s0021-9673(00)82016-6
PMID:7047545
Abstract

A gas chromatographic-mass spectrometric method for the simultaneous determination of captopril (SQ 14,255) and its disulphide (SQ 14,551) in biological fluids by means of selected ion monitoring is described. In order to prevent oxidative degradation, captopril was treated with N-ethylmaleimide (NEM). The captopril-NEM adduct and the disulphide were converted into the hexafluoroisopropyl esters, which were separated on a 10% Dexsil 300 GC column and determined by employing the captopril-N-butylmaleimide adducts as an internal standard. The blood and urine levels of captopril and its disulphide in dogs to which captopril had been administered orally were measured by the proposed method. The urinary excretion of these two substances in rats was also determined in a similar manner.

摘要

本文描述了一种气相色谱 - 质谱联用方法,通过选择离子监测同时测定生物体液中的卡托普利(SQ 14,255)及其二硫化物(SQ 14,551)。为防止氧化降解,卡托普利用N - 乙基马来酰亚胺(NEM)处理。卡托普利 - NEM加合物和二硫化物被转化为六氟异丙酯,在10% Dexsil 300气相色谱柱上分离,并以卡托普利 - N - 丁基马来酰亚胺加合物作为内标进行测定。用所提出的方法测量了口服卡托普利的犬体内卡托普利及其二硫化物的血药浓度和尿药浓度。还以类似方式测定了大鼠体内这两种物质的尿排泄量。

相似文献

1
Determination of captopril and its disulphide in biological fluids.生物流体中卡托普利及其二硫化物的测定。
J Chromatogr. 1982 Apr 30;239:585-94. doi: 10.1016/s0021-9673(00)82016-6.
2
Determination of captopril in biological fluids by gas-liquid chromatography.气液色谱法测定生物流体中的卡托普利。
J Chromatogr. 1980 Jan 25;188(1):177-83. doi: 10.1016/s0021-9673(00)88428-9.
3
Sensitive method for determination of captopril in biological fluids by gas chromatography-mass spectrometry.气相色谱-质谱联用法定量生物样品中卡托普利的灵敏方法。
J Chromatogr. 1987 Jun 5;417(1):79-87. doi: 10.1016/0378-4347(87)80093-2.
4
Quantitative determination of captopril in blood and captopril and its disulfide metabolites in plasma by gas chromatography.
J Pharm Sci. 1984 Mar;73(3):340-4. doi: 10.1002/jps.2600730313.
5
Combined gas chromatographic-mass spectrometric procedure for the measurement of captopril and sulfur-conjugated metabolites of captopril in plasma and urine.
J Chromatogr. 1984 Jan 13;305(1):83-93. doi: 10.1016/s0378-4347(00)83316-2.
6
Determination of total captopril in human plasma by gas chromatography-mass spectrometry with selected-ion monitoring after reduction of disulfides.在二硫化物还原后,采用气相色谱-质谱联用仪选择离子监测法测定人血浆中卡托普利的总量。
J Pharm Sci. 1984 Aug;73(8):1113-7. doi: 10.1002/jps.2600730822.
7
Determination of captopril in human blood and urine by GLC-selected ion monitoring mass spectrometry after oral coadministration with its isotopomer.口服卡托普利及其同位素异构体后,通过气相色谱-选择离子监测质谱法测定人血液和尿液中的卡托普利。
J Pharm Sci. 1982 Nov;71(11):1251-6. doi: 10.1002/jps.2600711117.
8
Determination of captopril in human blood by high-performance liquid chromatography with electrochemical detection.
J Chromatogr. 1982 Feb 12;227(2):445-51. doi: 10.1016/s0378-4347(00)80397-7.
9
Gas chromatography/selected ion monitoring mass spectrometric determination of captopril in human blood.气相色谱/选择离子监测质谱法测定人血中的卡托普利
Anal Chem. 1980 Jun;52(7):1086-9. doi: 10.1021/ac50057a021.
10
Identification and determination of the S-methyl metabolite of captopril in human plasma by selected-ion monitoring gas chromatography-mass spectrometry.采用选择离子监测气相色谱-质谱法鉴定和测定人血浆中卡托普利的S-甲基代谢物。
J Pharm Sci. 1984 Oct;73(10):1493-5. doi: 10.1002/jps.2600731046.

引用本文的文献

1
Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.卡托普利在健康受试者和心血管疾病患者中的药代动力学。
Clin Pharmacokinet. 1988 Apr;14(4):241-59. doi: 10.2165/00003088-198814040-00002.
2
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.卡托普利。其药效学和药代动力学特性的最新进展,以及在高血压和充血性心力衰竭中的治疗应用。
Drugs. 1988 Nov;36(5):540-600. doi: 10.2165/00003495-198836050-00003.